Wall Street Journal
By JENNIFER LEVITZ
Joseph Biederman, a top researcher on the use of psychiatric drugs in children, agreed to stop participating in several industry-funded drug trials and curb other activities pending the outcome of a Boston hospital’s inquiry into his potential conflicts of interest and disclosure obligations.
The deal, announced Tuesday by Massachusetts General Hospital, where [...]
New York Times
Psychiatrist to Curtail Industry-Funded Activities
By PAM BELLUCK
A prominent Harvard child psychiatrist will curtail activities financed by the drug industry while Massachusetts General Hospital investigates his failure for years to disclose the consulting fees he received from drug makers.
Dr. Joseph Biederman, a world-renowned and controversial researcher on childhood mental illness, has agreed to stop [...]
